Importance of dual delivery systems for bone tissue engineering

Journal of Controlled Release

Volumn 225, Issue , 2016, Pages 152-169

  Farokhi, Mehdi ^a   Mottaghitalab, Fatemeh ^b   Shokrgozar, Mohammad Ali ^a   Ou, Keng Liang ^c,d   Mao, Chuanbin ^e   Hosseinkhani, Hossein ^f  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e UNIVERSITY OF OKLAHOMA   (United States)

^f NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Bone regeneration; Dual drug delivery; Tissue engineering

Indexed keywords

BIOACTIVITY; BONE; TISSUE; TISSUE ENGINEERING;

BIOACTIVE FACTOR; BONE REGENERATION; BONE TISSUE ENGINEERING; BONE TISSUE FORMATION; BONE TISSUE REGENERATION; COMPLEX PROCESSES; MICROENVIRONMENTS; TISSUE PENETRATIONS;

TISSUE REGENERATION;

ALGINIC ACID; ANTIBIOTIC AGENT; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 14; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; CHITOSAN; CHITOSAN NANOPARTICLE; COLLAGEN; GROWTH DIFFERENTIATION FACTOR 5; GROWTH FACTOR; HYALURONIC ACID; HYDROXYAPATITE; KERATINOCYTE GROWTH FACTOR; MACROGOL; METRONIDAZOLE; NEU DIFFERENTIATION FACTOR; OSTEOGENIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; POLY(PROPYLENE FUMARATE); POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIC ACID; POLYURETHAN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG; VASCULOTROPIN; SIGNAL PEPTIDE;

ANGIOGENESIS; BONE DEVELOPMENT; BONE REGENERATION; BONE REMODELING; BONE TISSUE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG HALF LIFE; DRUG PENETRATION; DRUG RELEASE; EXTRACELLULAR MATRIX; FRACTURE HEALING; GENE DELIVERY SYSTEM; MICROENVIRONMENT; OSSIFICATION; PRIORITY JOURNAL; RAT; REGENERATION; REVIEW; TISSUE ENGINEERING; ANIMAL; BONE; HUMAN; INSTRUMENT STERILIZATION;

ANIMALS; BONE AND BONES; BONE REGENERATION; DRUG DELIVERY SYSTEMS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; STERILIZATION; TISSUE ENGINEERING;

EID: 84957010964     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2016.01.033     Document Type: Review

References (217)

1. J.R. Porter, T.T. Ruckh, and K.C. Popat Bone tissue engineering: a review in bone biomimetics and drug delivery strategies Biotechnol. Prog. 25 2009 1539 1560
2. M.A. Fernandez-Yague, S.A. Abbah, L. McNamara, D.I. Zeugolis, A. Pandit, and M.J. Biggs Biomimetic Approaches in Bone Tissue Engineering: Integrating Biological and Physicomechanical Strategies (Advanced drug delivery reviews) 2014
3. A. Kinaci, V. Neuhaus, and D.C. Ring Trends in bone graft use in the United States Orthopedics 37 2014 e783
4. F. Mottaghitalab, H. Hosseinkhani, M.A. Shokrgozar, C. Mao, M. Yang, and M. Farokhi Silk as a potential candidate for bone tissue engineering J. Control. Release 215 2015 112 128
5. S. Nandi, S. Roy, P. Mukherjee, B. Kundu, D. De, and D. Basu Orthopaedic applications of bone graft & graft substitutes: a review 2010
6. D.H. Kim, R. Rhim, L. Li, J. Martha, B.H. Swaim, R.J. Banco, L.G. Jenis, and S.G. Tromanhauser Prospective study of iliac crest bone graft harvest site pain and morbidity Spine J. 9 2009 886 892
7. J.E. Samorezov, and E. Alsberg Spatial regulation of controlled bioactive factor delivery for bone tissue engineering Adv. Drug Deliv. Rev. 2014
8. A. Nauth, B. Ristevski, R. Li, and E.H. Schemitsch Growth factors and bone regeneration: how much bone can we expect? Injury 42 2011 574 579
9. U. Food, and D. Administration InFUSE Bone Graft/LT-CAGE Lumbar Tapered Fusion Device-P000058, in 2014
10. R.R. Chen, and D.J. Mooney Polymeric growth factor delivery strategies for tissue engineering Pharm. Res. 20 2003 1103 1112
11. K.J. Rambhia, and P.X. Ma Controlled drug release for tissue engineering J. Control. Release 219 2015 119 128
12. Y.M. Kolambkar, J.D. Boerckel, K.M. Dupont, M. Bajin, N. Huebsch, D.J. Mooney, D.W. Hutmacher, and R.E. Guldberg Spatiotemporal delivery of bone morphogenetic protein enhances functional repair of segmental bone defects Bone 49 2011 485 492
13. N.J. Shah, M.L. Macdonald, Y.M. Beben, R.F. Padera, R.E. Samuel, and P.T. Hammond Tunable dual growth factor delivery from polyelectrolyte multilayer films Biomaterials 32 2011 6183 6193
14. F.-M. Chen, M. Zhang, and Z.-F. Wu Toward delivery of multiple growth factors in tissue engineering Biomaterials 31 2010 6279 6308
15. P. Tayalia, and D.J. Mooney Controlled growth factor delivery for tissue engineering Adv. Mater. 21 2009 3269 3285
16. J. Sohier, T. Vlugt, N. Cabrol, C. Van Blitterswijk, K. De Groot, and J. Bezemer Dual release of proteins from porous polymeric scaffolds J. Control. Release 111 2006 95 106
17. A. Roy, S. Jhunjhunwala, E. Bayer, M. Fedorchak, S.R. Little, and P.N. Kumta Porous calcium phosphate-poly (lactic-co-glycolic) acid composite bone cement: a viable tunable drug delivery system Mater. Sci. Eng. C 59 2016 92 101
18. X. Yu, A. Khalil, P.N. Dang, E. Alsberg, and W.L. Murphy Multilayered inorganic microparticles for tunable dual growth factor delivery Adv. Funct. Mater. 24 2014 3082 3093
19. Z.S. Patel, S. Young, Y. Tabata, J.A. Jansen, M.E. Wong, and A.G. Mikos Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model Bone 43 2008 931 940
20. S. Young, Z.S. Patel, J.D. Kretlow, M.B. Murphy, P.M. Mountziaris, L.S. Baggett, H. Ueda, Y. Tabata, J.A. Jansen, and M. Wong Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model Tissue Eng. A 15 2009 2347 2362
21. S. Reed, and B. Wu Sustained growth factor delivery in tissue engineering applications Ann. Biomed. Eng. 42 2014 1528 1536
22. R.L. Vonau, M.P. Bostrom, P. Aspenberg, and A.E. Sams Combination of growth factors inhibits bone ingrowth in the bone harvest chamber Clin. Orthop. Relat. Res. 386 2001 243 251
23. Y.-H. Kim, and Y. Tabata Dual-controlled release system of drugs for bone regeneration Adv. Drug Deliv. Rev. 2015
24. B.N. Brown, and S.F. Badylak Extracellular matrix as an inductive scaffold for functional tissue reconstruction Transl. Res. 163 2014 268 285
25. S.F. Badylak, D.O. Freytes, and T.W. Gilbert Extracellular matrix as a biological scaffold material: structure and function Acta Biomater. 5 2009 1 13
26. G.S. Schultz, and A. Wysocki Interactions between extracellular matrix and growth factors in wound healing Wound Repair Regen. 17 2009 153 162
27. M.M. Martino, P.S. Briquez, K. Maruyama, and J.A. Hubbell Extracellular matrix-inspired growth factor delivery systems for bone regeneration Adv. Drug Deliv. Rev. 2015
28. L. Macri, D. Silverstein, and R.A. Clark Growth factor binding to the pericellular matrix and its importance in tissue engineering Adv. Drug Deliv. Rev. 59 2007 1366 1381
29. J. Lee, J.J. Yoo, A. Atala, and S.J. Lee The effect of controlled release of PDGF-BB from heparin-conjugated electrospun PCL/gelatin scaffolds on cellular bioactivity and infiltration Biomaterials 33 2012 6709 6720
30. M.M. Martino, and J.A. Hubbell The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain FASEB J. 24 2010 4711 4721
31. M.M. Martino, P.S. Briquez, A. Ranga, M.P. Lutolf, and J.A. Hubbell Heparin-binding domain of fibrin (ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix Proc. Natl. Acad. Sci. 110 2013 4563 4568
32. L. De Laporte, J.J. Rice, F. Tortelli, and J.A. Hubbell Tenascin C promiscuously binds growth factors via its fifth fibronectin type III-like domain PLoS One 8 2013 e62076
33. Z. Upton, L. Cuttle, A. Noble, M. Kempf, G. Topping, J. Malda, Y. Xie, J. Mill, D.G. Harkin, and O. Kravchuk Vitronectin: growth factor complexes hold potential as a wound therapy approach J. Investig. Dermatol. 128 2008 1535 1544
34. R. Cancedda Cartilage and bone extracellular matrix Curr. Pharm. Des. 15 2009 1334 1348
35. K.J. Manton, D.F. Leong, S.M. Cool, and V. Nurcombe Disruption of heparan and chondroitin sulfate signaling enhances mesenchymal stem cell-derived osteogenic differentiation via bone morphogenetic protein signaling pathways Stem Cells 25 2007 2845 2854
36. M. Yang, G. Zhou, H. Castano-Izquierdo, Y. Zhu, and C. Mao Biomineralization of natural collagenous nanofibrous membranes and their potential use in bone tissue engineering J. Biomed. Nanotechnol. 11 2015 447 456
37. C. Sfeir, L. Ho, B.A. Doll, K. Azari, and J.O. Hollinger Fracture repair Bone Regeneration and Repair 2005 Springer 21 44
38. M.-A. Lauzon, É. Bergeron, B. Marcos, and N. Faucheux Bone repair: new developments in growth factor delivery systems and their mathematical modeling J. Control. Release 162 2012 502 520
39. K. Hankenson, K. Gagne, and M. Shaughnessy Extracellular signaling molecules to promote fracture healing and bone regeneration Adv. Drug Deliv. Rev. 2015
40. Y. Tanaka, S. Nakayamada, and Y. Okada Osteoblasts and osteoclasts in bone remodeling and inflammation Curr. Drug Targets Inflamm. Allergy 4 2005 325 328
41. R. Detsch, and A.R. Boccaccini The role of osteoclasts in bone tissue engineering J. Tissue Eng. Regen. Med. 2014
42. M.M. Deckers, M. Karperien, C. van der Bent, T. Yamashita, S.E. Papapoulos, and C.W. Löwik Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation Endocrinology 141 2000 1667 1674
43. Q. Yang, K.P. McHugh, S. Patntirapong, X. Gu, L. Wunderlich, and P.V. Hauschka VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and β 3-integrin Matrix Biol. 27 2008 589 599
44. R. Abou-Khalil, F. Yang, M. Mortreux, S. Lieu, Y.Y. Yu, M. Wurmser, C. Pereira, F. Relaix, T. Miclau, and R.S. Marcucio Delayed bone regeneration is linked to chronic inflammation in murine muscular dystrophy J. Bone Miner. Res. 29 2014 304 315
45. J. Aronson Current concepts review-limb-lengthening, skeletal reconstruction, and bone transport with the Ilizarov method∗ J. Bone Joint Surg. 79 1997 1243 1258
46. M.K. Nguyen, and E. Alsberg Bioactive factor delivery strategies from engineered polymer hydrogels for therapeutic medicine Prog. Polym. Sci. 39 2014 1235 1265
47. V. Luginbuehl, L. Meinel, H.P. Merkle, and B. Gander Localized delivery of growth factors for bone repair Eur. J. Pharm. Biopharm. 58 2004 197 208
48. E. Piskin Biologically modified polymeric biomaterial surfaces: introduction Biologically Modified Polymeric Biomaterial Surfaces 1992 Springer 3 7
49. G. Schmidmaier, B. Wildemann, A. Stemberger, N. Haas, and M. Raschke Biodegradable poly (d, l-lactide) coating of implants for continuous release of growth factors J. Biomed. Mater. Res. 58 2001 449 455
50. G.E. Riedel, and A. Valentin-Opran Clinical evaluation of rhBMP-2/ACS in orthopedic trauma: a progress report Orthopedics 22 1999 663 665
51. Y. Bai, G. Yin, Z. Huang, X. Liao, X. Chen, Y. Yao, and X. Pu Localized delivery of growth factors for angiogenesis and bone formation in tissue engineering Int. Immunopharmacol. 16 2013 214 223
52. G. Zhang, and L.J. Suggs Matrices and scaffolds for drug delivery in vascular tissue engineering Adv. Drug Deliv. Rev. 59 2007 360 373
53. E.P. Ivanova, K. Bazaka, and R.J. Crawford 2 - natural polymer biomaterials: advanced applications New Functional Biomaterials for Medicine and Healthcare 2014 Woodhead Publishing 32 70
54. L. Luca, A.-L. Rougemont, B.H. Walpoth, R. Gurny, and O. Jordan The effects of carrier nature and pH on rhBMP-2-induced ectopic bone formation J. Control. Release 147 2010 38 44
55. S.-H. Lee, and H. Shin Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering Adv. Drug Deliv. Rev. 59 2007 339 359
56. B. ŘÍhová Immunomodulating activities of soluble synthetic polymer-bound drugs Adv. Drug Deliv. Rev. 54 2002 653 674
57. D. Puppi, F. Chiellini, A. Piras, and E. Chiellini Polymeric materials for bone and cartilage repair Prog. Polym. Sci. 35 2010 403 440
58. Z.-Y. Lin, Z.-X. Duan, X.-D. Guo, J.-F. Li, H.-W. Lu, Q.-X. Zheng, D.-P. Quan, and S.-H. Yang Bone induction by biomimetic PLGA-(PEG-ASP) n copolymer loaded with a novel synthetic BMP-2-related peptide in vitro and in vivo J. Control. Release 144 2010 190 195
59. H. Schliephake, H.A. Weich, C. Dullin, R. Gruber, and S. Frahse Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid - an experimental study in rats Biomaterials 29 2008 103 110
60. G. Wei, Q. Jin, W.V. Giannobile, and P.X. Ma The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres Biomaterials 28 2007 2087 2096
61. M.E. Oest, K.M. Dupont, H.J. Kong, D.J. Mooney, and R.E. Guldberg Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects J. Orthop. Res. 25 2007 941 950
62. F.C. van de Watering, J.D. Molkenboer-Kuenen, O.C. Boerman, J.J. van den Beucken, and J.A. Jansen Differential loading methods for BMP-2 within injectable calcium phosphate cement J. Control. Release 164 2012 283 290
63. E. Verron, J. Bouler, and J. Guicheux Controlling the biological function of calcium phosphate bone substitutes with drugs Acta Biomater. 8 2012 3541 3551
64. S. Yamano, K. Haku, T. Yamanaka, J. Dai, T. Takayama, R. Shohara, K. Tachi, M. Ishioka, S. Hanatani, and S. Karunagaran The effect of a bioactive Collagen membrane releasing PDGF or GDF-5 on bone regeneration Biomaterials 35 2014 2446 2453
65. Z.S. Patel, M. Yamamoto, H. Ueda, Y. Tabata, and A.G. Mikos Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2 Acta Biomater. 4 2008 1126 1138
66. P.C. Bessa, R. Machado, S. Nürnberger, D. Dopler, A. Banerjee, A.M. Cunha, J.C. Rodríguez-Cabello, H. Redl, M. van Griensven, and R.L. Reis Thermoresponsive self-assembled elastin-based nanoparticles for delivery of BMPs J. Control. Release 142 2010 312 318
67. M. Farokhi, F. Mottaghitalab, M.A. Shokrgozar, J. Ai, J. Hadjati, and M. Azami Bio-hybrid silk fibroin/calcium phosphate/PLGA nanocomposite scaffold to control the delivery of vascular endothelial growth factor Mater. Sci. Eng. C 35 2014 401 410
68. M.S. Bae, J.-Y. Ohe, J.B. Lee, D.N. Heo, W. Byun, H. Bae, Y.-D. Kwon, and I.K. Kwon Photo-cured hyaluronic acid-based hydrogels containing growth and differentiation factor 5 (GDF-5) for bone tissue regeneration Bone 59 2014 189 198
69. S.-W. Kang, J.-S. Kim, K.-S. Park, B.-H. Cha, J.-H. Shim, J.Y. Kim, D.-W. Cho, J.-W. Rhie, and S.-H. Lee Surface modification with fibrin/hyaluronic acid hydrogel on solid-free form-based scaffolds followed by BMP-2 loading to enhance bone regeneration Bone 48 2011 298 306
70. L. Cao, J.A. Werkmeister, J. Wang, V. Glattauer, K.M. McLean, and C. Liu Bone regeneration using photocrosslinked hydrogel incorporating rhBMP-2 loaded 2-N, 6-O-sulfated chitosan nanoparticles Biomaterials 35 2014 2730 2742
71. B. De la Riva, C. Nowak, E. Sánchez, A. Hernández, M. Schulz-Siegmund, M.K. Pec, A. Delgado, and C. Évora VEGF-controlled release within a bone defect from alginate/chitosan/PLA-H scaffolds Eur. J. Pharm. Biopharm. 73 2009 50 58
72. T. Kaito, A. Myoui, K. Takaoka, N. Saito, M. Nishikawa, N. Tamai, H. Ohgushi, and H. Yoshikawa Potentiation of the activity of bone morphogenetic protein-2 in bone regeneration by a PLA-PEG/hydroxyapatite composite Biomaterials 26 2005 73 79
73. E. Quinlan, A. López-Noriega, E. Thompson, H.M. Kelly, S.A. Cryan, and F.J. O'Brien Development of collagen-hydroxyapatite scaffolds incorporating PLGA and alginate microparticles for the controlled delivery of rhBMP-2 for bone tissue engineering J. Control. Release 198 2015 71 79
74. J. Xue, M. He, H. Liu, Y. Niu, A. Crawford, P.D. Coates, D. Chen, R. Shi, and L. Zhang Drug loaded homogeneous electrospun PCL/gelatin hybrid nanofiber structures for anti-infective tissue regeneration membranes Biomaterials 35 2014 9395 9405
75. M. Dadsetan, T. Guda, M.B. Runge, D. Mijares, R.Z. LeGeros, J.P. LeGeros, D.T. Silliman, L. Lu, J.C. Wenke, and P.R.B. Baer Effect of calcium phosphate coating and rhBMP-2 on bone regeneration in rabbit calvaria using poly (propylene fumarate) scaffolds Acta Biomater. 18 2015 9 20
76. B. Li, T. Yoshii, A.E. Hafeman, J.S. Nyman, J.C. Wenke, and S.A. Guelcher The effects of rhBMP-2 released from biodegradable polyurethane/microsphere composite scaffolds on new bone formation in rat femora Biomaterials 30 2009 6768 6779
77. S.K. Nandi, B. Kundu, J. Mukherjee, A. Mahato, S. Datta, and V.K. Balla Converted marine coral hydroxyapatite implants with growth factors: in vivo bone regeneration Mater. Sci. Eng. C 49 2015 816 823
78. Y. Takahashi, M. Yamamoto, and Y. Tabata Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and β-tricalcium phosphate Biomaterials 26 2005 4856 4865
79. L. Xia, D. Zeng, X. Sun, Y. Xu, L. Xu, D. Ye, X. Zhang, X. Jiang, and Z. Zhang Engineering of bone using rhBMP-2-loaded mesoporous silica bioglass and bone marrow stromal cells for oromaxillofacial bone regeneration Microporous Mesoporous Mater. 173 2013 155 165
80. W.R. Gombotz, and D.K. Pettit Biodegradable polymers for protein and peptide drug delivery Bioconjug. Chem. 6 1995 332 351
81. K. Odelius, P. Plikk, and A.-C. Albertsson The influence of composition of porous copolyester scaffolds on reactions induced by irradiation sterilization Biomaterials 29 2008 129 140
82. A.S. Baume, P.C. Boughton, N.V. Coleman, and A.J. Ruys 10 - sterilization of tissue scaffolds P. Tomlins, Characterisation and Design of Tissue Scaffolds 2016 Woodhead Publishing 225 244
83. G. ABUHANOGLU, and A.Y. ÖZER Radiation effects on pharmaceuticals FABAD J. Pharm. Sci. 35 2010 203 217
84. M. Silindir, and A. Ozer Sterilization methods and the comparison of E-beam sterilization with gamma radiation sterilization FABAD J. Pharm. Sci. 34 2009 43 53
85. S. Yan, L. Xiaoqiang, L. Shuiping, M. Xiumei, and S. Ramakrishna Controlled release of dual drugs from emulsion electrospun nanofibrous mats Colloids Surf. B: Biointerfaces 73 2009 376 381
86. D. Cheng, and M.V. Sefton Dual delivery of placental growth factor and vascular endothelial growth factor from poly (hydroxyethyl methacrylate-co-methyl methacrylate) microcapsules containing doubly transfected luciferase-expressing L929 cells Tissue Eng. A 15 2009 1929 1939
87. R. Chapanian, and B. Amsden Combined and sequential delivery of bioactive VEGF 165 and HGF from poly (trimethylene carbonate) based photo-cross-linked elastomers J. Control. Release 143 2010 53 63
88. F.-M. Chen, Y. An, R. Zhang, and M. Zhang New insights into and novel applications of release technology for periodontal reconstructive therapies J. Control. Release 149 2011 92 110
89. S. Browne, and A. Pandit Multi-modal delivery of therapeutics using biomaterial scaffolds J. Mater. Chem. B 2 2014 6692 6707
90. T.N. Vo, F.K. Kasper, and A.G. Mikos Strategies for controlled delivery of growth factors and cells for bone regeneration Adv. Drug Deliv. Rev. 64 2012 1292 1309
91. T.P. Richardson, M.C. Peters, A.B. Ennett, and D.J. Mooney Polymeric system for dual growth factor delivery Nat. Biotechnol. 19 2001 1029 1034
92. R.R. Chen, E.A. Silva, W.W. Yuen, and D.J. Mooney Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation Pharm. Res. 24 2007 258 264
93. T. Suciati, D. Howard, J. Barry, N.M. Everitt, K.M. Shakesheff, and F.R. Rose Zonal release of proteins within tissue engineering scaffolds J. Mater. Sci. Mater. Med. 17 2006 1049 1056
94. S. Facca, C. Cortez, C. Mendoza-Palomares, N. Messadeq, A. Dierich, A. Johnston, D. Mainard, J.-C. Voegel, F. Caruso, and N. Benkirane-Jessel Active multilayered capsules for in vivo bone formation Proc. Natl. Acad. Sci. 107 2010 3406 3411
95. H. Layman, M. Sacasa, A.E. Murphy, A.M. Murphy, S.M. Pham, and F.M. Andreopoulos Co-delivery of FGF-2 and G-CSF from gelatin-based hydrogels as angiogenic therapy in a murine critical limb ischemic model Acta Biomater. 5 2009 230 239
96. S.M. Jay, B.R. Shepherd, J.W. Andrejecsk, T.R. Kyriakides, J.S. Pober, and W.M. Saltzman Dual delivery of VEGF and MCP-1 to support endothelial cell transplantation for therapeutic vascularization Biomaterials 31 2010 3054 3062
97. R.A. Peattie, E.R. Rieke, E.M. Hewett, R.J. Fisher, X.Z. Shu, and G.D. Prestwich Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants Biomaterials 27 2006 1868 1875
98. H. Zhang, X. Jia, F. Han, J. Zhao, Y. Zhao, Y. Fan, and X. Yuan Dual-delivery of VEGF and PDGF by double-layered electrospun membranes for blood vessel regeneration Biomaterials 34 2013 2202 2212
99. J.E. Tengood, R. Ridenour, R. Brodsky, A.J. Russell, and S.R. Little Sequential delivery of basic fibroblast growth factor and platelet-derived growth factor for angiogenesis Tissue Eng. A 17 2011 1181 1189
100. C.M. Riley, P.W. Fuegy, M.A. Firpo, X.Z. Shu, G.D. Prestwich, and R.A. Peattie Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels Biomaterials 27 2006 5935 5943
101. F.R. Formiga, B. Pelacho, E. Garbayo, I. Imbuluzqueta, P. Díaz-Herráez, G. Abizanda, J.J. Gavira, T. Simón-Yarza, E. Albiasu, and E. Tamayo Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration J. Control. Release 173 2014 132 139
102. J.H. Kim, Y. Jung, S.-H. Kim, K. Sun, J. Choi, H.C. Kim, Y. Park, and S.H. Kim The enhancement of mature vessel formation and cardiac function in infarcted hearts using dual growth factor delivery with self-assembling peptides Biomaterials 32 2011 6080 6088
103. T. Holland, E. Bodde, V. Cuijpers, L. Baggett, Y. Tabata, A. Mikos, and J. Jansen Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair Osteoarthr. Cartil. 15 2007 187 197
104. J.S. Park, K. Na, D.G. Woo, H.N. Yang, and K.-H. Park Determination of dual delivery for stem cell differentiation using dexamethasone and TGF-β3 in/on polymeric microspheres Biomaterials 30 2009 4796 4805
105. T.A. Holland, Y. Tabata, and A.G. Mikos Dual growth factor delivery from degradable oligo (poly (ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering J. Control. Release 101 2005 111 125
106. S.M. Lim, S.H. Oh, H.H. Lee, S.H. Yuk, G.I. Im, and J.H. Lee Dual growth factor-releasing nanoparticle/hydrogel system for cartilage tissue engineering J. Mater. Sci. Mater. Med. 21 2010 2593 2600
107. A. Jaklenec, A. Hinckfuss, B. Bilgen, D.M. Ciombor, R. Aaron, and E. Mathiowitz Sequential release of bioactive IGF-I and TGF-β 1 from PLGA microsphere-based scaffolds Biomaterials 29 2008 1518 1525
108. B. Jiang, G. Zhang, and E.M. Brey Dual delivery of chlorhexidine and platelet-derived growth factor-BB for enhanced wound healing and infection control Acta Biomater. 9 2013 4976 4984
109. A. Clark, T.A. Milbrandt, J.Z. Hilt, and D.A. Puleo Mechanical properties and dual drug delivery application of poly (lactic-co-glycolic acid) scaffolds fabricated with a poly (β-amino ester) porogen Acta Biomater. 10 2014 2125 2132
110. S.N. Khan, M.P. Bostrom, and J.M. Lane Bone growth factors Orthop. Clin. N. Am. 31 2000 375 387
111. J. van der Stok, H. Wang, S. Amin Yavari, M. Siebelt, M. Sandker, J.H. Waarsing, J.A. Verhaar, H. Jahr, A.A. Zadpoor, and S.C. Leeuwenburgh Enhanced bone regeneration of cortical segmental bone defects using porous titanium scaffolds incorporated with colloidal gelatin gels for time- and dose-controlled delivery of dual growth factors Tissue Eng. A 19 2013 2605 2614
112. L.N. Luong, J. Ramaswamy, and D.H. Kohn Effects of osteogenic growth factors on bone marrow stromal cell differentiation in a mineral-based delivery system Biomaterials 33 2012 283 294
113. Y. Tabata, and Y. Ikada Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities Biomaterials 20 1999 2169 2175
114. Y. Zhang, V. Madhu, A.S. Dighe, J.N. Irvine Jr., and Q. Cui Osteogenic response of human adipose-derived stem cells to BMP-6, VEGF, and combined VEGF plus BMP-6 in vitro Growth Factors 30 2012 333 343
115. T. Matsubara, K. Kida, A. Yamaguchi, K. Hata, F. Ichida, H. Meguro, H. Aburatani, R. Nishimura, and T. Yoneda BMP2 regulates osterix through Msx2 and Runx2 during osteoblast differentiation J. Biol. Chem. 283 2008 29119 29125
116. J. Roldan, R. Detsch, S. Schaefer, E. Chang, M. Kelantan, W. Waiss, T. Reichert, G. Gurtner, and U. Deisinger Bone formation and degradation of a highly porous biphasic calcium phosphate ceramic in presence of BMP-7, VEGF and mesenchymal stem cells in an ectopic mouse model J. Cranio-Maxillofac. Surg. 38 2010 423 430
117. G. Li, K. Corsi-Payne, B. Zheng, A. Usas, H. Peng, and J. Huard The dose of growth factors influences the synergistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation Tissue Eng. A 15 2009 2123 2133
118. T.H. Howell, J.P. Fiorellini, D.W. Paquette, S. Offenbacher, W.V. Giannobile, and S.E. Lynch A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease J. Periodontol. 68 1997 1186 1193
119. S. Lu, J. Lam, J.E. Trachtenberg, E.J. Lee, H. Seyednejad, J.J. van den Beucken, Y. Tabata, M.E. Wong, J.A. Jansen, and A.G. Mikos Dual growth factor delivery from bilayered, biodegradable hydrogel composites for spatially-guided osteochondral tissue repair Biomaterials 35 2014 8829 8839
120. C.A. Simmons, E. Alsberg, S. Hsiong, W.J. Kim, and D.J. Mooney Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells Bone 35 2004 562 569
121. T.J. Cho, L.C. Gerstenfeld, and T.A. Einhorn Differential temporal expression of members of the transforming growth factor β superfamily during murine fracture healing J. Bone Miner. Res. 17 2002 513 520
122. P.B. Malafaya, G.A. Silva, and R.L. Reis Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications Adv. Drug Deliv. Rev. 59 2007 207 233
123. M. Sokolsky-Papkov, K. Agashi, A. Olaye, K. Shakesheff, and A.J. Domb Polymer carriers for drug delivery in tissue engineering Adv. Drug Deliv. Rev. 59 2007 187 206
124. E.C. Novosel, C. Kleinhans, and P.J. Kluger Vascularization is the key challenge in tissue engineering Adv. Drug Deliv. Rev. 63 2011 300 311
125. D. Komatsu, and M. Hadjiargyrou Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair Bone 34 2004 680 688
126. C. Maes, I. Stockmans, K. Moermans, R. Van Looveren, N. Smets, P. Carmeliet, R. Bouillon, and G. Carmeliet Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival J. Clin. Investig. 113 2004 188
127. J. Street, M. Bao, S. Bunting, F.V. Peale, N. Ferrara, H. Steinmetz, J. Hoeffel, J.L. Cleland, A. Daugherty, and N. van Bruggen Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover Proc. Natl. Acad. Sci. 99 2002 9656 9661
128. D. Kaigler, Z. Wang, K. Horger, D.J. Mooney, and P.H. Krebsbach VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects J. Bone Miner. Res. 21 2006 735 744
129. H. Eckardt, M. Ding, M. Lind, E.S. Hansen, K. Christensen, and I. Hvid Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model J. Bone Joint Surg. Br. Vol. 87 2005 1434 1438
130. N. Kakudo, K. Kusumoto, Y.B. Wang, Y. Iguchi, and Y. Ogawa Immunolocalization of vascular endothelial growth factor on intramuscular ectopic osteoinduction by bone morphogenetic protein-2 Life Sci. 79 2006 1847 1855
131. Y.C. Huang, D. Kaigler, K.G. Rice, P.H. Krebsbach, and D.J. Mooney Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration J. Bone Miner. Res. 20 2005 848 857
132. M.S. Kang, J.-H. Kim, R.K. Singh, J.-H. Jang, and H.-W. Kim Therapeutic-designed electrospun bone scaffolds: mesoporous bioactive nanocarriers in hollow fiber composites to sequentially deliver dual growth factors Acta Biomater. 16 2015 103 116
133. L. Li, G. Zhou, Y. Wang, G. Yang, S. Ding, and S. Zhou Controlled dual delivery of BMP-2 and dexamethasone by nanoparticle-embedded electrospun nanofibers for the efficient repair of critical-sized rat calvarial defect Biomaterials 37 2015 218 229
134. K. Matsuo, and N. Irie Osteoclast-osteoblast communication Arch. Biochem. Biophys. 473 2008 201 209
135. M.H. Alkhraisat, C. Rueda, J. Cabrejos-Azama, J. Lucas-Aparicio, F.T. Mariño, J.T. Garcia-Denche, L.B. Jerez, U. Gbureck, and E.L. Cabarcos Loading and release of doxycycline hyclate from strontium-substituted calcium phosphate cement Acta Biomater. 6 2010 1522 1528
136. M.H. Pelletier, L. Malisano, P.J. Smitham, K. Okamoto, and W.R. Walsh The compressive properties of bone cements containing large doses of antibiotics J. Arthroplast. 24 2009 454 460
137. A. Ratier, I. Gibson, S. Best, M. Freche, J. Lacout, and F. Rodriguez Setting characteristics and mechanical behaviour of a calcium phosphate bone cement containing tetracycline Biomaterials 22 2001 897 901
138. S. Bose, and S. Tarafder Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review Acta Biomater. 8 2012 1401 1421
139. P.J. Bouletreau, S.M. Warren, J.A. Spector, Z.M. Peled, R.P. Gerrets, J.A. Greenwald, and M.T. Longaker Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing Plast. Reconstr. Surg. 109 2002 2384 2397
140. M. Ramazanoglu, R. Lutz, P. Rusche, L. Trabzon, G.T. Kose, C. Prechtl, and K.A. Schlegel Bone response to biomimetic implants delivering BMP-2 and VEGF: an immunohistochemical study J. Cranio-Maxillofac. Surg. 41 2013 826 835
141. W.X. Cai, L.W. Zheng, C.L. Li, L. Ma, M. Ehrbar, F.E. Weber, and R.A. Zwahlen Effect of different rhbmp-2 and tg-vegf ratios on the formation of heterotopic bone and neovessels BioMed Research International, 2014 2014
142. H. Peng, V. Wright, A. Usas, B. Gearhart, H.-C. Shen, J. Cummins, and J. Huard Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4 J. Clin. Invest. 110 2002 751 759
143. U. Mayr-Wohlfart, J. Waltenberger, H. Hausser, S. Kessler, K.-P. Günther, C. Dehio, W. Puhl, and R. Brenner Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts Bone 30 2002 472 477
144. M.T. Engsig, Q.-J. Chen, T.H. Vu, A.-C. Pedersen, B. Therkidsen, L.R. Lund, K. Henriksen, T. Lenhard, N.T. Foged, and Z. Werb Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones J. Cell Biol. 151 2000 879 890
145. J. Fiedler, F. Leucht, J. Waltenberger, C. Dehio, and R.E. Brenner VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells Biochem. Biophys. Res. Commun. 334 2005 561 568
146. J.N. Zara, R.K. Siu, X. Zhang, J. Shen, R. Ngo, M. Lee, W. Li, M. Chiang, J. Chung, and J. Kwak High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo Tissue Eng. A 17 2011 1389 1399
147. M. van de Weert, W.E. Hennink, and W. Jiskoot Protein instability in poly (lactic-co-glycolic acid) microparticles Pharm. Res. 17 2000 1159 1167
148. G. Crotts, H. Sah, and T.G. Park Adsorption determines in-vitro protein release rate from biodegradable microspheres: quantitative analysis of surface area during degradation J. Control. Release 47 1997 101 111
149. H. Kaneko, T. Arakawa, H. Mano, T. Kaneda, A. Ogasawara, M. Nakagawa, Y. Toyama, Y. Yabe, M. Kumegawa, and Y. Hakeda Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts Bone 27 2000 479 486
150. F. Liu, N. Bloch, K.R. Bhushan, A.M. De Grand, E. Tanaka, S. Solazzo, P.M. Mertyna, N. Goldberg, J.V. Frangioni, and R.E. Lenkinski Humoral BMP-2 is sufficient for inducing breast cancer microcalcification Mol. Imaging 7 2008 175
151. M.M. Stevens Biomaterials for bone tissue engineering Mater. Today 11 2008 18 25
152. X. Wang, B. Ding, and B. Li Biomimetic electrospun nanofibrous structures for tissue engineering Mater. Today 16 2013 229 241
153. S.J. Hollister Porous scaffold design for tissue engineering Nat. Mater. 4 2005 518 524
154. J.R. Jones, P.D. Lee, and L.L. Hench Hierarchical porous materials for tissue engineering Philos. Trans. R. Soc. Lond. A 364 2006 263 281
155. Y. Su, Q. Su, W. Liu, M. Lim, J.R. Venugopal, X. Mo, S. Ramakrishna, S.S. Al-Deyab, and M. El-Newehy Controlled release of bone morphogenetic protein 2 and dexamethasone loaded in core-shell PLLACL-collagen fibers for use in bone tissue engineering Acta Biomater. 8 2012 763 771
156. S. Liu, M. Qin, C. Hu, F. Wu, W. Cui, T. Jin, and C. Fan Tendon healing and anti-adhesion properties of electrospun fibrous membranes containing bFGF loaded nanoparticles Biomaterials 34 2013 4690 4701
157. M. Farokhi, F. Mottaghitalab, J. Ai, and M.A. Shokrgozar Sustained release of platelet-derived growth factor and vascular endothelial growth factor from silk/calcium phosphate/PLGA based nanocomposite scaffold Int. J. Pharm. 454 2013 216 225
158. R.E. Geuze, L.F. Theyse, D.H. Kempen, H.A. Hazewinkel, H.Y. Kraak, F.C. Öner, W.J. Dhert, and J. Alblas A differential effect of bone morphogenetic protein-2 and vascular endothelial growth factor release timing on osteogenesis at ectopic and orthotopic sites in a large-animal model Tissue Eng. A 18 2012 2052 2062
159. S.-S. Noh, S.H. Bhang, W.-G. La, S. Lee, J.-Y. Shin, Y.-J. Ma, H.-K. Jang, S. Kang, M. Jin, and J. Park A dual delivery of substance P and bone morphogenetic protein-2 for mesenchymal stem cell recruitment and bone regeneration Tissue Eng. A 21 2015 1275 1287
160. D. Suárez-González, J.S. Lee, A. Diggs, Y. Lu, B. Nemke, M. Markel, S.J. Hollister, and W.L. Murphy Controlled multiple growth factor delivery from bone tissue engineering scaffolds via designed affinity Tissue Eng. A 20 2013 2077 2087
161. D.H. Kempen, L. Lu, A. Heijink, T.E. Hefferan, L.B. Creemers, A. Maran, M.J. Yaszemski, and W.J. Dhert Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration Biomaterials 30 2009 2816 2825
162. P. Yilgor, R.A. Sousa, R.L. Reis, N. Hasirci, and V. Hasirci Effect of scaffold architecture and BMP-2/BMP-7 delivery on in vitro bone regeneration J. Mater. Sci. Mater. Med. 21 2010 2999 3008
163. D.H. Choi, C.H. Park, I.H. Kim, H.J. Chun, K. Park, and D.K. Han Fabrication of core-shell microcapsules using PLGA and alginate for dual growth factor delivery system J. Control. Release 147 2010 193 201
164. A. Hernández, R. Reyes, E. Sanchez, M. Rodríguez-Évora, A. Delgado, and C. Evora In vivo osteogenic response to different ratios of BMP-2 and VEGF released from a biodegradable porous system J. Biomed. Mater. Res. A 100 2012 2382 2391
165. P. Yilgor, K. Tuzlakoglu, R.L. Reis, N. Hasirci, and V. Hasirci Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering Biomaterials 30 2009 3551 3559
166. F.B. Basmanav, G.T. Kose, and V. Hasirci Sequential growth factor delivery from complexed microspheres for bone tissue engineering Biomaterials 29 2008 4195 4204
167. Y. Liu, B. Möller, J. Wiltfang, P.H. Warnke, and H. Terheyden Tissue engineering of a vascularized bone graft of critical size with an osteogenic and angiogenic factor-based in vivo bioreactor Tissue Eng. A 20 2014 3189 3197
168. Y. Zhang, X. Cheng, J. Wang, Y. Wang, B. Shi, C. Huang, X. Yang, and T. Liu Novel chitosan/collagen scaffold containing transforming growth factor-β1 DNA for periodontal tissue engineering Biochem. Biophys. Res. Commun. 344 2006 362 369
169. Y. Zhang, J. Song, B. Shi, Y. Wang, X. Chen, C. Huang, X. Yang, D. Xu, X. Cheng, and X. Chen Combination of scaffold and adenovirus vectors expressing bone morphogenetic protein-7 for alveolar bone regeneration at dental implant defects Biomaterials 28 2007 4635 4642
170. X.-Q. Jiang, J.-G. Chen, S. Gittens, C.-J. Chen, X.-L. Zhang, and Z.-Y. Zhang The ectopic study of tissue-engineered bone with hBMP-4 gene modified bone marrow stromal cells in rabbits Chin. Med. J. 118 2005 281 288
171. R.M. Schek, E.N. Wilke, S.J. Hollister, and P.H. Krebsbach Combined use of designed scaffolds and adenoviral gene therapy for skeletal tissue engineering Biomaterials 27 2006 1160 1166
172. X.L. Xu, J. Lou, T. Tang, K.W. Ng, J. Zhang, C. Yu, and K. Dai Evaluation of different scaffolds for BMP-2 genetic orthopedic tissue engineering J. Biomed. Mater. Res. B Appl. Biomater. 75 2005 289 303
173. K. Dai, X. Xu, T. Tang, Z. Zhu, C. Yu, J. Lou, and X. Zhang Repairing of goat tibial bone defects with BMP-2 Gene-modified tissue-engineered bone Calcif. Tissue Int. 77 2005 55 61
174. O. Jeon, S.J. Song, H.S. Yang, S.-H. Bhang, S.-W. Kang, M.A. Sung, J.H. Lee, and B.-S. Kim Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery Biochem. Biophys. Res. Commun. 369 2008 774 780
175. M. Varkey, S.A. Gittens, and H. Uludag Growth factor delivery for bone tissue repair: an update Expert Opin. Drug Deliv. 1 2004 19 36
176. C. Zhang, K.-z. Wang, H. Qiang, Y.-l. Tang, Q. Li, M. Li, and X.-q. Dang Angiopoiesis and bone regeneration via co-expression of the hVEGF and hBMP genes from an adeno-associated viral vector in vitro and in vivo Acta Pharmacol. Sin. 31 2010 821 830
177. J. Jiang, C.-Y. Fan, and B.-F. Zeng Experimental construction of BMP2 and VEGF gene modified tissue engineering bone in vitro Int. J. Mol. Sci. 12 2011 1744 1755
178. O.B. Betz, V.M. Betz, A. Nazarian, C.G. Pilapil, M.S. Vrahas, M.L. Bouxsein, L.C. Gerstenfeld, T.A. Einhorn, and C.H. Evans Direct percutaneous gene delivery to enhance healing of segmental bone defects J. Bone Joint Surg. 88 2006 355 365
179. A. Baltzer, C. Lattermann, J. Whalen, P. Wooley, K. Weiss, M. Grimm, S. Ghivizzani, P. Robbins, and C. Evans Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene Gene Ther. 7 2000 734 739
180. M. Menendez, D. Clark, M. Carlton, D. Flanigan, G. Jia, S. Sammet, S. Weisbrode, M. Knopp, and A. Bertone Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral model Osteoarthr. Cartil. 19 2011 1066 1075
181. A. Bertone, D. Pittman, M. Bouxsein, J. Li, B. Clancy, and H. Seeherman Adenoviral-mediated transfer of human BMP-6 gene accelerates healing in a rabbit ulnar osteotomy model J. Orthop. Res. 22 2004 1261 1270
182. Y. Zhang, N. Cheng, R. Miron, B. Shi, and X. Cheng Delivery of PDGF-B and BMP-7 by mesoporous bioglass/silk fibrin scaffolds for the repair of osteoporotic defects Biomaterials 33 2012 6698 6708
183. S.-Y. Park, K.-H. Kim, S.-Y. Shin, K.-T. Koo, Y.-M. Lee, and Y.-J. Seol Dual delivery of rhPDGF-BB and bone marrow mesenchymal stromal cells expressing the BMP2 gene enhance bone formation in a critical-sized defect model Tissue Eng. A 19 2013 2495 2505
184. R. Gruber, F. Karreth, B. Kandler, G. Fuerst, A. Rot, M.B. Fischer, and G. Watzek Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions Platelets 15 2004 29 35
185. B. Gharibi, M.S. Ghuman, and F.J. Hughes Akt-and Erk-mediated regulation of proliferation and differentiation during PDGFRβ-induced MSC self-renewal J. Cell. Mol. Med. 16 2012 2789 2801
186. Y. Zhang, B. Shi, C. Li, Y. Wang, Y. Chen, W. Zhang, T. Luo, and X. Cheng The synergetic bone-forming effects of combinations of growth factors expressed by adenovirus vectors on chitosan/collagen scaffolds J. Control. Release 136 2009 172 178
187. T. Luo, W. Zhang, B. Shi, X. Cheng, and Y. Zhang Enhanced bone regeneration around dental implant with bone morphogenetic protein 2 gene and vascular endothelial growth factor protein delivery Clin. Oral Implants Res. 23 2012 467 473
188. O. Bleiziffer, E. Eriksson, F. Yao, R.E. Horch, and U. Kneser Gene transfer strategies in tissue engineering J. Cell. Mol. Med. 11 2007 206 223
189. L.C. Rose, C. Kucharski, and H. Uludaʇ Protein expression following non-viral delivery of plasmid DNA coding for basic FGF and BMP-2 in a rat ectopic model Biomaterials 33 2012 3363 3374
190. S.G. Madanagopal, D. Seligson, and C.S. Roberts The antibiotic cement nail for infection after tibial nailing Orthopedics 27 2004 709 712
191. S. Babin, P. Graf, J. North, and E. Schvingt Infection following closed intramedullary nailing by Kuntscher's method in 1059 fractures Int. Orthop. 5 1980 271 276
192. K.W. Klemm Treatment of infected pseudarthrosis of the femur and tibia with an interlocking nail Clin. Orthop. Relat. Res. 212 1986 174 181
193. D. Paley, J.E. Herzenberg, and N. Bor Fixator-assisted nailing of femoral and tibial deformities Tech. Orthop. 12 1997 260 275
194. A. Simpson, A. Cole, and J. Kenwright Leg lengthening over an intramedullary nail J. Bone Joint Surg. Br. Vol. 81 1999 1041 1045
195. M. Khatod, M.J. Botte, D.B. Hoyt, R.S. Meyer, J.M. Smith, and W.H. Akeson Outcomes in open tibia fractures: relationship between delay in treatment and infection J. Trauma Acute Care Surg. 55 2003 949 954
196. C.G. Zalavras, M.J. Patzakis, P.D. Holtom, and R. Sherman Management of open fractures Infect. Dis. Clin. N. Am. 19 2005 915 929
197. G. Giavaresi, V. Borsari, M. Fini, R. Giardino, V. Sambri, P. Gaibani, and R. Soffiatti Preliminary investigations on a new gentamicin and vancomycin-coated PMMA nail for the treatment of bone and intramedullary infections: an experimental study in the rabbit J. Orthop. Res. 26 2008 785 792
198. J.W. Costerton, P.S. Stewart, and E. Greenberg Bacterial biofilms: a common cause of persistent infections Science 284 1999 1318 1322
199. D. Campoccia, L. Montanaro, and C.R. Arciola The significance of infection related to orthopedic devices and issues of antibiotic resistance Biomaterials 27 2006 2331 2339
200. G. Wang, S.-J. Liu, S.W.-N. Ueng, and E.-C. Chan The release of cefazolin and gentamicin from biodegradable PLA/PGA beads Int. J. Pharm. 273 2004 203 212
201. D. Han, W. Liu, Q. Ao, and G. Wang Optimal delivery systems for bone morphogenetic proteins in orthopedic applications should model initial tissue repair structures by using a heparin-incorporated fibrin-fibronectin matrix Med. Hypotheses 71 2008 374 378
202. L.D. Silverman, L. Lukashova, O.T. Herman, J.M. Lane, and A.L. Boskey Release of gentamicin from a tricalcium phosphate bone implant J. Orthop. Res. 25 2007 23 29
203. S.R. Jackson, K.C. Richelsoph, H.S. Courtney, J.C. Wenke, J.G. Branstetter, J.D. Bumgardner, and W.O. Haggard Preliminary in vitro evaluation of an adjunctive therapy for extremity wound infection reduction: rapidly resorbing local antibiotic delivery J. Orthop. Res. 27 2009 903 908
204. J. Price, A. Tencer, D. Arm, and G. Bohach Controlled release of antibiotics from coated orthopedic implants J. Biomed. Mater. Res. 30 1996 281 286
205. V. Alt, A. Bitschnau, F. Böhner, K.E. Heerich, E. Magesin, A. Sewing, T. Pavlidis, G. Szalay, C. Heiss, and U. Thormann Effects of gentamicin and gentamicin-RGD coatings on bone ingrowth and biocompatibility of cementless joint prostheses: an experimental study in rabbits Acta Biomater. 7 2011 1274 1280
206. G. Schmidmaier, M. Lucke, B. Wildemann, N.P. Haas, and M. Raschke Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review Injury 37 2006 S105 S112
207. D.O. Schairer, J.S. Chouake, J.D. Nosanchuk, and A.J. Friedman The potential of nitric oxide releasing therapies as antimicrobial agents Virulence 3 2012 271 279
208. N.M. Van Sorge, F.C. Beasley, I. Gusarov, D.J. Gonzalez, M. von Köckritz-Blickwede, S. Anik, A.W. Borkowski, P.C. Dorrestein, E. Nudler, and V. Nizet Methicillin-resistant Staphylococcus aureus bacterial nitric-oxide synthase affects antibiotic sensitivity and skin abscess development J. Biol. Chem. 288 2013 6417 6426
209. T.-K. Nguyen, R. Selvanayagam, K.K. Ho, R. Chen, S.K. Kutty, S.A. Rice, N. Kumar, N. Barraud, H.T. Duong, and C. Boyer Co-delivery of nitric oxide and antibiotic using polymeric nanoparticles Chem. Sci. 2016
210. C. Khurana, A.K. Vala, N. Andhariya, O. Pandey, and B. Chudasama Antibacterial activities of silver nanoparticles and antibiotic-adsorbed silver nanoparticles against biorecycling microbes Environ. Sci.: Processes Impacts 16 2014 2191 2198
211. R. Balaji Raja, and P. Singh Synergistic effect of silver nanoparticles with the cephalexin antibiotic against the test strains Bioresearch Bulletin 2 4 2013
212. P.P. Arias, U.F. Tafin, B. Bétrisey, S. Vogt, A. Trampuz, and O. Borens Activity of bone cement loaded with daptomycin alone or in combination with gentamicin or PEG600 against Staphylococcus epidermidis biofilms Injury 46 2015 249 253
213. C. Strobel, N. Bormann, A. Kadow-Romacker, G. Schmidmaier, and B. Wildemann Sequential release kinetics of two (gentamicin and BMP-2) or three (gentamicin, IGF-I and BMP-2) substances from a one-component polymeric coating on implants J. Control. Release 156 2011 37 45
214. D.W. Chen, Y.-H. Hsu, J.-Y. Liao, S.-J. Liu, J.-K. Chen, and S.W.-N. Ueng Sustainable release of vancomycin, gentamicin and lidocaine from novel electrospun sandwich-structured PLGA/Collagen nanofibrous membranes Int. J. Pharm. 430 2012 335 341
215. P. Sanz-Ruiz, E. Paz, J. Abenojar, J.C. del Real, J. Vaquero, and F. Forriol Effects of vancomycin, cefazolin and test conditions on the wear behavior of bone cement J. Arthroplast. 29 2014 16 22
216. D.-W. Lee, Y.-P. Yun, K. Park, and S.E. Kim Gentamicin and bone morphogenic protein-2 (BMP-2)-delivering heparinized-titanium implant with enhanced antibacterial activity and osteointegration Bone 50 2012 974 982
217. M.E. Bertazzoni, A. Benini, B. Magnan, and P. Bartolozzi Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty J. Antimicrob. Chemother. 53 2004 329 334